Literature DB >> 1706210

Dilatation of the prostatic urethra with 35 mm balloon.

J McLoughlin1, P F Keane, R Jager, K P Gill, L Machann, G Williams.   

Abstract

A series of 54 men, 25 with acute urinary retention and 29 with cytometrically proven bladder outflow obstruction (BOO), underwent dilatation of the prostatic urethra using a 35 mm fixed diameter, low compliance balloon. In 42 patients this was performed under cystoscopic guidance and in 12 patients under fluoroscopic control. Three months following dilatation, 13/27 patients (48%) with BOO who returned for review were rendered unobstructed and 19/27 (70%) were symptomatically improved. By 6 months only 3 remained unobstructed but 15 remained symptomatically improved. Nine months after dilatation 14 patients retained symptomatic improvement but only 2 remained unobstructed. Of the 25 patients treated for acute retention only 6 voided spontaneously, 1 of these relapsing into retention at 2 months and another at 4 months. No patient was rendered unobstructed but 2 patients (who declined prostatectomy) noted an improvement in their obstructive symptoms at both 3 and 6 months. No patient developed retrograde ejaculation following dilatation. Balloon dilatation to 35 mm has no role in acute urinary retention but may have a role in younger men with BOO who wish to avoid prostatectomy and the risk of retrograde ejaculation. In these patients careful follow-up is required.

Entities:  

Mesh:

Year:  1991        PMID: 1706210     DOI: 10.1111/j.1464-410x.1991.tb15104.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Balloon dilatation of the prostate--should it have a place in the urologist's armamentarium?

Authors:  J A Vale; P D Miller; R S Kirby
Journal:  J R Soc Med       Date:  1993-02       Impact factor: 5.344

2.  Efficacy and safety of transurethral split of prostate for benign prostatic hyperplasia: a meta-analysis.

Authors:  Yiyu Huang; Jiaxin Li; Shan Yang; Daozhang Yuan; Shusheng Wang
Journal:  BMC Urol       Date:  2020-09-03       Impact factor: 2.264

Review 3.  Sexual function in patients with benign prostatic hyperplasia.

Authors:  P K Hegarty; N J Hegarty; J M Fitzpatrick
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.